Heissig Philipp, Klein Philipp M, Hadwiger Philipp, Wagner Ernst
Pharmaceutical Biotechnology, Department of Pharmacy, Center for Nanoscience, Ludwig-Maximilians-Universität, Munich, Germany.
Axolabs GmbH, Kulmbach, Germany.
Mol Ther Nucleic Acids. 2016 Mar 1;5(3):e288. doi: 10.1038/mtna.2016.6.
siRNA and microRNA are promising therapeutic agents, which are engaged in a natural mechanism called RNA interference that modulates gene expression posttranscriptionally. For intracellular delivery of such nucleic acid triggers, we use sequence-defined cationic polymers manufactured through solid phase chemistry. They consist of an oligoethanamino amide core for siRNA complexation and optional domains for nanoparticle shielding and cell targeting. Due to the small size of siRNA, electrostatic complexes with polycations are less stable, and consequently intracellular delivery is less efficient. Here we use DNA oligomers as adaptors to increase size and charge of cargo siRNA, resulting in increased polyplex stability, which in turn boosts transfection efficiency. Extending a single siRNA with a 181-nucleotide DNA adaptor is sufficient to provide maximum gene silencing aided by cationic polymers. Interestingly, this simple strategy was far more effective than merging defined numbers (4-10) of siRNA units into one DNA scaffolded construct. For DNA attachment, the 3' end of the siRNA passenger strand was beneficial over the 5' end. The impact of the attachment site however was resolved by introducing bioreducible disulfides at the connection point. We also show that DNA adaptors provide the opportunity to readily link additional functional domains to siRNA. Exemplified by the covalent conjugation of the endosomolytic influenza peptide INF-7 to siRNA via a DNA backbone strand and complexing this construct with a targeting polymer, we could form a highly functional polyethylene glycol-shielded polyplex to downregulate a luciferase gene in folate receptor-positive cells.
小干扰RNA(siRNA)和微小RNA(miRNA)是很有前景的治疗剂,它们参与一种称为RNA干扰的天然机制,该机制在转录后调节基因表达。为了实现此类核酸触发剂的细胞内递送,我们使用通过固相化学制造的序列定义阳离子聚合物。它们由用于siRNA复合的寡聚乙胺酰胺核心以及用于纳米颗粒屏蔽和细胞靶向的可选结构域组成。由于siRNA尺寸小,与聚阳离子形成的静电复合物稳定性较差,因此细胞内递送效率较低。在这里,我们使用DNA寡聚物作为接头来增加货物siRNA的尺寸和电荷,从而提高多聚体稳定性,进而提高转染效率。用181个核苷酸的DNA接头延伸单个siRNA足以在阳离子聚合物的辅助下实现最大程度的基因沉默。有趣的是,这种简单的策略比将确定数量(4-10)的siRNA单元合并到一个DNA支架构建体中要有效得多。对于DNA连接,siRNA过客链的3'端比5'端更有利。然而,通过在连接点引入可生物还原的二硫键解决了连接位点的影响。我们还表明,DNA接头提供了将其他功能域轻松连接到siRNA的机会。以内溶酶体流感肽INF-7通过DNA主链与siRNA共价结合并将该构建体与靶向聚合物复合为例,我们可以形成一种高度功能性的聚乙二醇屏蔽多聚体,以下调叶酸受体阳性细胞中的荧光素酶基因。